home / stock / pddpf / pddpf news


PDDPF News and Press, Medexus Pharmaceuticals Inc From 10/15/19

Stock Information

Company Name: Medexus Pharmaceuticals Inc
Stock Symbol: PDDPF
Market: OTC

Menu

PDDPF PDDPF Quote PDDPF Short PDDPF News PDDPF Articles PDDPF Message Board
Get PDDPF Alerts

News, Short Squeeze, Breakout and More Instantly...

PDDPF - Medexus Announces Changes to Senior Management

MONTREAL, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ”) (TSXV: MDP, OTCQB: PDDPF) today announced changes to the Company’s senior management team. Effective immediately, Mr. Sylvain Chrétien will no longer serve as the Company...

PDDPF - Medexus Reports Annual Meeting Results

TORONTO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSXV: MDP, OTCQB: PDDPF) announces voting results from its Annual Meeting of Shareholders held on September 18, 2019 in Toronto, Ontario (the “ Mee...

PDDPF - Medexus Reports Health Quality Ontario Recommends Gliolan® for Public Reimbursement

MONTREAL, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, has recom...

PDDPF - Medexus Pharmaceuticals beats on revenue

Medexus Pharmaceuticals ( OTCPK:PDDPF ): Q1 Net loss of $2.2M. More news on: Medexus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PDDPF - Medexus Pharmaceuticals Reports Operating and Financial Results for the First Quarter of Fiscal 2020

Record Revenue of $16.1 Million $0.5 million of Adjusted EBITDA Medexus management to host conference call at 4:30 PM ET on Thursday, August 22, 2019 TORONTO and CHICAGO and MONTREAL, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” o...

PDDPF - Medexus Pharmaceuticals Schedules First Quarter Fiscal 2020 Conference Call

MONTREAL, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 4:30 PM Eastern Time on Thursday, August 22, 2019 to discuss the Company&#...

PDDPF - Medexus Announces DTC Eligibility of its Common Shares in the United States

MONTREAL, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSXV: MDP, OTCQB: PDDPF) is pleased to announce that the Company's common shares traded in the United States, under the symbol PDDPF, are Depository Trust C...

PDDPF - Medexus Pharmaceuticals reports Q4 results

Medexus Pharmaceuticals ( OTCPK:PDDPF ): Q4 Adj. EBITDA of C$0.1M More news on: Medexus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PDDPF - Medexus Pharmaceuticals Announces Operating and Financial Results for Fourth Quarter and Full Fiscal Year Ended March 31, 2019

Generated $2.4 million of Adjusted EBITDA for fiscal year 2019 Medexus management to host conference call at 4:30 PM ET on July 8, 2019 MONTREAL, July 08, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTC...

PDDPF - Medexus Pharmaceuticals Schedules Fourth Quarter and Fiscal 2019 Conference Call

MONTREAL, June 28, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 4:30 PM Eastern Time on Monday, July 8, 2019 to discuss the Company’...

Previous 10 Next 10